https://www.selleckchem.com/pr....oducts/isoxazole-9-i
s ineffective for COPD, COPD readmissions had decreased at an earlier timepoint (October 2012), when penalties were announced for conditions other than COPD. Based on this, we believe early, broad interventions decreased readmissions, such that no difference was seen at this later timepoints despite institution of COPD-specific penalties. We did not detect decreases in either all-cause or COPD-related readmission rates at either timepoint. Although this would suggest that HRRP penalty was ineffective for COPD, COPD readmission
Like
Comment
Share
